TotalMarketCap

United Therapeutics

UTHRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$23.554 B

$549.16 +3.07%

Close of 12 Oct 2026

As of 12 Oct 2026, United Therapeutics (UTHR) has a market capitalization of $23.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.18B

#883 by revenue

Earnings

$1.33B

#310 by earnings

Shares outstanding

42,890,692

Latest filing cover page

P/E ratio

17.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #20ZoetisZTS$30.9B
  2. #21Roivant SciencesROIV$25.6B
  3. #22United TherapeuticsUTHR$23.6B
  4. #23Genmab A/SGMAB$23.1B
  5. #24InsmedINSM$22.0B

What if United Therapeutics were worth as much as…

Open the what-if tool →

Gold $29.0T

$676,712.25

Per share 1,232× higher

Bitcoin $1.66T

$38,772.54

Per share 70.6× higher

Nvidia $5.53T

$128,830.94

Per share 235× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for United Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 13 Oct 2026. Read the methodology.